Literature DB >> 25104184

Guidelines for treatment of recurrent or metastatic head and neck cancer.

P Parikh, V Patil, J P Agarwal, P Chaturvedi, A Vaidya, S Rathod, V Noronha, A Joshi, A Jamshed, G S Bhattacharya, S Gupta, C Desai, S H Advani, P Pai, S Laskar, A Ramesh, P N Mohapatra, A K Vaid, M Deshpande, A A Ranade, A Vora, R Baral, M A Hussain, B Rajan, A K Dcruz, K Prabhash1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25104184     DOI： 10.4103/0019-509X.137896

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN： 0019-509X            Impact factor:   1.224


× No keyword cloud information.
  12 in total

1.  Anti-EGFR treatment effects on laryngeal cancer stem cells.

Authors:  Glaucia Maria de Mendonça Fernandes; Ana Lívia Silva Galbiatti-Dias; Leticia Antunes Muniz Ferreira; Vilson Serafim Junior; Gabriela Helena Rodrigues-Fleming; Juliana Garcia de Oliveira-Cucolo; Patrícia Matos Biselli-Chicote; Rosa Sayoko Kawasaki-Oyama; José Victor Maniglia; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Metronomic palliative chemotherapy in maxillary sinus tumor.

Authors:  Vijay M Patil; Vanita Noronh; Amit Joshi; Ashay Karpe; Vikas Talreja; Arun Chandrasekharan; Sachin Dhumal; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2016 Apr-Jun

3.  Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers.

Authors:  Vijay M Patil; Vanita Noronha; Amit Joshi; Rakesh Pinninti; Sachin Dhumal; Atanu Bhattacharjee; Kumar Prabhash
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jul-Sep

4.  The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.

Authors:  Xiaodong Feng; Qingqiong Luo; Han Zhang; Han Wang; Wantao Chen; Guangxun Meng; Fuxiang Chen
Journal:  J Exp Clin Cancer Res       Date:  2017-06-21

5.  A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers.

Authors:  Vanita Noronha; Vijay M Patil; Amit Joshi; Atanu Bhattacharjee; Davinder Paul; Sachin Dhumal; Shashikant Juvekar; Supreeta Arya; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2017 Jan-Mar

6.  Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence.

Authors:  Sundaram Subramanian; Nithya Sridharan; V Balasundaram; Sameer Chaudhari
Journal:  South Asian J Cancer       Date:  2018 Jul-Sep

7.  Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patients.

Authors:  Vijay Patil; Amit Joshi; Vanita Noronha; Atanu Bhattacharjee; Sachin Dhumal; M V Chandrakanth; Ashay Karpe; Vikas Talreja; Arun Chandrasekharan; Siddharth Turkar; Nikhil Pande; Anant Ramaswamy; Kumar Prabhash
Journal:  South Asian J Cancer       Date:  2018 Oct-Dec

8.  Safety and efficacy of nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: An Indian rural hospital experience.

Authors:  Shyamji Rawat; Hemu Tandan; Sanandan Patel; Sameer Chaudhari
Journal:  South Asian J Cancer       Date:  2019 Jan-Mar

9.  A systematic review of standard treatment guidelines in India.

Authors:  Paresh Girdharlal Koli; Nilima A Kshirsagar; Yashashri C Shetty; Dhvani Mehta; Yashaswini Mittal; Urwashi Parmar
Journal:  Indian J Med Res       Date:  2019-06       Impact factor: 2.375

10.  Nimotuzumab with intensity-modulated radiation therapy in unresectable and platinum-ineligible locally advanced head-and-neck cancer.

Authors:  K Satish Srinivas; Raja Sundaram; C V Divyambika; Sameer Chaudhari
Journal:  South Asian J Cancer       Date:  2020 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.